MARK A. GOLDSMITH - President and Chief Executive Officer, Director at Revolution Medicines, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Chief Executive Officer, Director
Issuer Symbol
RVMD, RVMDW on Nasdaq
All Insider Reports
All Insider Reports

MARK A. GOLDSMITH - trading volume in the past year for Revolution Medicines, Inc.

Holdings reported by MARK A. GOLDSMITH for Revolution Medicines, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 67,424 $6,925,119 $102.71 06 Feb 2026 Trust
Common Stock 256,479 $138,498 $0.5400 06 Feb 2026 Direct
Stock Option (Right to Buy) 144,493 06 Feb 2026 Direct Common Stock

Transactions reported by MARK A. GOLDSMITH for Revolution Medicines, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.